156 related articles for article (PubMed ID: 38278561)
41. Supplementation of nicotinic acid with NAMPT inhibitors results in loss of in vivo efficacy in NAPRT1-deficient tumor models.
O'Brien T; Oeh J; Xiao Y; Liang X; Vanderbilt A; Qin A; Yang L; Lee LB; Ly J; Cosino E; LaCap JA; Ogasawara A; Williams S; Nannini M; Liederer BM; Jackson P; Dragovich PS; Sampath D
Neoplasia; 2013 Dec; 15(12):1314-29. PubMed ID: 24403854
[TBL] [Abstract][Full Text] [Related]
42. Oleate ameliorates palmitate-induced reduction of NAMPT activity and NAD levels in primary human hepatocytes and hepatocarcinoma cells.
Penke M; Schuster S; Gorski T; Gebhardt R; Kiess W; Garten A
Lipids Health Dis; 2017 Oct; 16(1):191. PubMed ID: 28974242
[TBL] [Abstract][Full Text] [Related]
43. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes.
Hsu CP; Oka S; Shao D; Hariharan N; Sadoshima J
Circ Res; 2009 Aug; 105(5):481-91. PubMed ID: 19661458
[TBL] [Abstract][Full Text] [Related]
44. AMPK phosphorylates NAMPT to regulate NAD
Liao X; Huang X; Li X; Qiu X; Li M; Liu R; He T; Tang Q
Open Biol; 2022 Oct; 12(10):220213. PubMed ID: 36196536
[TBL] [Abstract][Full Text] [Related]
45. Discovery of DS68702229 as a Potent, Orally Available NAMPT (Nicotinamide Phosphoribosyltransferase) Activator.
Akiu M; Tsuji T; Iida K; Sogawa Y; Terayama K; Yokoyama M; Tanaka J; Asano D; Honda T; Sakurai K; Pinkerton AB; Nakamura T
Chem Pharm Bull (Tokyo); 2021; 69(11):1110-1122. PubMed ID: 34719594
[TBL] [Abstract][Full Text] [Related]
46. Tanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK/Nampt pathway.
Zhang HS; Chen XY; Wu TC; Zhang FJ
J Cell Physiol; 2014 Sep; 229(9):1193-201. PubMed ID: 24414799
[TBL] [Abstract][Full Text] [Related]
47. EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells.
Mutz CN; Schwentner R; Aryee DNT; Bouchard EDJ; Mejia EM; Hatch GM; Kauer MO; Katschnig AM; Ban J; Garten A; Alonso J; Banerji V; Kovar H
Oncotarget; 2017 Apr; 8(15):24679-24693. PubMed ID: 28160567
[TBL] [Abstract][Full Text] [Related]
48. Novel carbon skeletons activate human NicotinAMide Phosphoribosyl Transferase (NAMPT) enzyme in biochemical assay.
Almeida KH; Avalos-Irving L; Berardinelli S; Chauvin K; Yanez S
PLoS One; 2023; 18(3):e0283428. PubMed ID: 36996070
[TBL] [Abstract][Full Text] [Related]
49. Increasing NAD synthesis in muscle via nicotinamide phosphoribosyltransferase is not sufficient to promote oxidative metabolism.
Frederick DW; Davis JG; Dávila A; Agarwal B; Michan S; Puchowicz MA; Nakamaru-Ogiso E; Baur JA
J Biol Chem; 2015 Jan; 290(3):1546-58. PubMed ID: 25411251
[TBL] [Abstract][Full Text] [Related]
50. Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters.
Zhang T; Berrocal JG; Frizzell KM; Gamble MJ; DuMond ME; Krishnakumar R; Yang T; Sauve AA; Kraus WL
J Biol Chem; 2009 Jul; 284(30):20408-17. PubMed ID: 19478080
[TBL] [Abstract][Full Text] [Related]
51. Discovery of small-molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and their preclinical neuroprotective activity.
Yao H; Liu M; Wang L; Zu Y; Wu C; Li C; Zhang R; Lu H; Li F; Xi S; Chen S; Gu X; Liu T; Cai J; Wang S; Yang M; Xing GG; Xiong W; Hua L; Tang Y; Wang G
Cell Res; 2022 Jun; 32(6):570-584. PubMed ID: 35459935
[TBL] [Abstract][Full Text] [Related]
52. Identification of small-molecule urea derivatives as novel NAMPT inhibitors via pharmacophore-based virtual screening.
Ozgencil F; Eren G; Ozkan Y; Guntekin-Ergun S; Cetin-Atalay R
Bioorg Med Chem; 2020 Jan; 28(1):115217. PubMed ID: 31818629
[TBL] [Abstract][Full Text] [Related]
53. Novel β-carboline-based indole-4,7-quinone derivatives as NAD(P)H: Quinone-oxidoreductase-1 inhibitor with potent antitumor activities by inducing reactive oxygen species, apoptosis, and DNA damage.
Guo Y; Xu L; Ling C; Yang T; Zheng W; Lv J; Guo Q; Chen B
Chem Biol Drug Des; 2020 Dec; 96(6):1433-1446. PubMed ID: 32592323
[TBL] [Abstract][Full Text] [Related]
54. Effect of Phosphoribosyltransferase Down-regulation on Malignant Glioma Cell Characteristics.
Kamada M; Ikeda K; Manome Y
Anticancer Res; 2020 Sep; 40(9):4895-4905. PubMed ID: 32878777
[TBL] [Abstract][Full Text] [Related]
55. Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death.
Velma GR; Krider IS; Alves ETM; Courey JM; Laham MS; Thatcher GRJ
J Med Chem; 2024 Apr; 67(8):5999-6026. PubMed ID: 38580317
[TBL] [Abstract][Full Text] [Related]
56. P7C3 neuroprotective chemicals function by activating the rate-limiting enzyme in NAD salvage.
Wang G; Han T; Nijhawan D; Theodoropoulos P; Naidoo J; Yadavalli S; Mirzaei H; Pieper AA; Ready JM; McKnight SL
Cell; 2014 Sep; 158(6):1324-1334. PubMed ID: 25215490
[TBL] [Abstract][Full Text] [Related]
57. Divergent metabolic responses dictate vulnerability to NAMPT inhibition in ovarian cancer.
Kudo K; Nomura M; Sakamoto Y; Ito S; Morita M; Kawai M; Yamashita Y; Ito K; Yamada H; Shima H; Yaegashi N; Tanuma N
FEBS Lett; 2020 May; 594(9):1379-1388. PubMed ID: 31950503
[TBL] [Abstract][Full Text] [Related]
58. SIRT1 selectively exerts the metabolic protective effects of hepatocyte nicotinamide phosphoribosyltransferase.
Higgins CB; Mayer AL; Zhang Y; Franczyk M; Ballentine S; Yoshino J; DeBosch BJ
Nat Commun; 2022 Feb; 13(1):1074. PubMed ID: 35228549
[TBL] [Abstract][Full Text] [Related]
59. Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin.
Bolandghamat Pour Z; Nourbakhsh M; Mousavizadeh K; Madjd Z; Ghorbanhosseini SS; Abdolvahabi Z; Hesari Z; Ezzati Mobasser S
BMC Cancer; 2019 Nov; 19(1):1027. PubMed ID: 31675930
[TBL] [Abstract][Full Text] [Related]
60. CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells.
Grozio A; Sociali G; Sturla L; Caffa I; Soncini D; Salis A; Raffaelli N; De Flora A; Nencioni A; Bruzzone S
J Biol Chem; 2013 Sep; 288(36):25938-25949. PubMed ID: 23880765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
